According to IMARC Group’s latest report, titled “Super disintegrants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.'the global Super disintegrants market reached a value of US$ 361.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 551.3 Billion by 2027, exhibiting at a CAGR of 7.45% during 2022-2027.

 Market Overview:

Super disintegrants represent modified disintegrants added in drug formulations to facilitate the breakup of tablets and capsules into smaller particles. They aid in increasing the incorporation of the drug and the solvability of active pharmaceutical ingredients (APIs) in the body, thereby minimizing the disintegration time or oral solid dosage forms and improving their efficiency. Super disintegrants exhibit several beneficial properties, including good molding, high compatibility, improved bioavailability, efficient compressibility, enhanced hydration capacity, optimal flow characteristics, etc. Presently, they are widely available in synthetic and natural variants and utilized in various therapeutic areas, including cardiovascular, infectious, hematological, neurological, gastrointestinal, and inflammatory diseases.

Request for a PDF sample of this report: https://www.imarcgroup.com/superdisintegrants-market/requestsample

The escalating demand for solid dosage medicines and the increasing number of individuals suffering from numerous age-related and chronic diseases are primarily augmenting the superdisintegrants market. Furthermore, the expanding geriatric population and the growing acceptability of generic drugs are positively influencing the global market. Apart from this, the widespread adoption of superdisintegrants in the production of orally disintegrating tablets (ODTs) for antipsychotics, antidepressants, antimigraine, sedatives, etc., is also bolstering the market growth. Moreover, the elevating investments by leading manufacturers in product development and innovation of novel formulations to retain a competitive edge in the market are acting as significant growth-inducing factors. Besides this, the implementation of stringent regulations by government bodies across countries for the use of safer alternatives in the pharmaceuticals industry is further catalyzing the global market. Additionally, the rising prevalence of neurological disorders and the inflating popularity of telemedicine, owing to the sudden outbreak of the COVID-19 pandemic, are expected to fuel the superdisintegrants market in the coming years.

Checkout Now: https://www.imarcgroup.com/checkout?id=2073&method=1

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape:

• Asahi Kasei Corporation
• Ashland Global Specialty Chemicals Inc.
• Avantor Inc.
• BASF SE
• Corel Pharma Chem
• DFE Pharma GmbH & Co. KG
• DuPont de Nemours Inc.
• JRS Pharma GmbH & Co. KG
• Merck KGaA
• Nippon Soda Co. Ltd.
• Roquette Frères
• Sigachi Industries Limited.

Key Market Segmentation:

Breakup by Product:

• Croscarmellose Sodium
• Crospovidone
• Sodium Starch Glycolate
• Ion Exchange Resin
• Modified Cellulose
• Others

Breakup by Type:

• Natural Superdisintegrant
• Synthetic Superdisintegrant
• Others

Breakup by Dosage Form:

• Tablets and Capsules
• Mouth-Dissolving Films

Breakup by Therapeutic Areas:

• Gastrointestinal
• Cardiovascular
• Neurology
• Oncology
• Hematology
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4641&flag=C

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800